Daxor Corporation is the global leader in blood volume measurement technology focused on blood testing innovation. The BVA-100® (Blood Volume Analyzer) is the only diagnostic blood test cleared by the FDA to provide safe, 98% accurate, objective quantification of blood volume status and composition compared to patient-specific norms to help guide individualized volume management in a wide variety of medical conditions including critical care and COVID-19 related symptoms.
Over 60,000+ tests have been performed to evaluate blood volume and is being used daily in major centers across the U.S. In a prospective randomized control trial, the BVA test showed that optimization of intravascular blood volume led to a 44% change in treatment decisions and reduced mortality by up to 66% versus conventional therapy in critically-ill patients.
Daxor's mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for all.